Lion Street Advisors’s AbbVie ABBV Stock Holding History

Lion Street Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$801K	Sell	6,983 -1,676	-19%	-$341K	0.28%	75
2025 Q2	$1.61M	Buy	8,659 +1,052	+14%	+$196K	0.49%	41
2025 Q1	$1.59M	Sell	7,607 -184	-2%	-$35.8K	0.51%	39
2024 Q4	$1.38M	Buy	7,791 +1,914	+33%	+$352K	0.44%	44
2024 Q3	$1.16M	Buy	5,877 +9	+0.2%	+$1.68K	0.4%	50
2024 Q2	$1.01M	Sell	5,868 -62	-1%	-$10.3K	0.37%	54
2024 Q1	$919K	Hold	5,930	–	–	0.38%	54
2023 Q4	$919K	Sell	5,930 -5,007	-46%	-$730K	0.38%	54
2023 Q3	$1.63M	Buy	10,937 +3,798	+53%	+$558K	0.53%	29
2023 Q2	$819K	Sell	7,139 -3,172	-31%	-$465K	0.28%	73
2023 Q1	$1.64M	Buy	10,311 +5,547	+116%	+$848K	0.51%	26
2022 Q4	$546K	Sell	4,764 -3,639	-43%	-$558K	0.29%	56
2022 Q3	$1.13M	Buy	8,403 +3,639	+76%	+$522K	0.56%	15
2022 Q2	$542K	Buy	4,764 +53	+1%	+$8.1K	0.28%	58
2022 Q1	$760K	Sell	4,711 -50	-1%	-$7.26K	0.39%	36
2021 Q4	$648K	Sell	4,761 -490	-9%	-$57.9K	0.32%	48
2021 Q3	$567K	Buy	+5,251	New	+$600K	0.31%	54
2020 Q2	–	Sell	-381	Closed	-$29K	–	28
2020 Q1	$29K	Buy	+381	New	+$32.5K	0.16%	76

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lion Street Advisors's ABBV Position: Q3 2025 in Review

Lion Street Advisors reduced its AbbVie (ABBV) stake by 19% in Q3 2025, selling an estimated $341K and leaving 6,983 shares worth $801K. The position accounts for 0.28% of the portfolio, ranked #75.

Lion Street Advisors first reported a position in ABBV in Q1 2020 and has held it in 18 quarters since. The position peaked at $1.64M in Q1 2023. 3,915 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Lion Street Advisors held 6,983 shares of AbbVie worth $801K as of Q3 2025.
Lion Street Advisors sold 1,676 AbbVie shares in Q3 2025, an estimated $341K.
AbbVie made up 0.28% of Lion Street Advisors's portfolio in Q3 2025, its #75 holding.
Lion Street Advisors first reported a position in AbbVie in Q1 2020 and has held it in 18 quarters since.
Lion Street Advisors's AbbVie position peaked at $1.64M in Q1 2023.
3,915 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.